Earnings Call · Q4 FY2024·2025-01-31

Q4 24EPS +1.89%·Rev n/aQ3 24EPS +2.74%·Rev n/aQ2 24EPS -0.38%·Rev n/aQ1 24EPS +3.59%·Rev n/a⚠ consensus missing

AbbVie Inc. ABBV

Liz Shea — Vice President, Investor Relations

Rob Michael — Chief Executive Officer

Jeff Stewart — Executive Vice President, Chief Commercial Officer

Carrie Strom — Senior Vice President, AbbVie, President, Global Allergan Aesthetics

Roopal Thakkar — Executive Vice President, Research & Development, Chief Scientific Officer

Scott Reents — Executive Vice President, Chief Financial Officer

+4.7%1d on move date+5.2% vs SPY3d+8.1%5d+9.9%

Research tier

Behavioral profile computed for 6 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ABBV calls or request research access.

More ABBV calls Browse calls Request research access